You have 9 free searches left this month | for more free features.

MOR03087 (MOR202)

Showing 1 - 25 of 35

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multiple Myeloma Trial in Austria, Germany (MOR03087 phase 1 dose escalation, MOR03087, Dexamethasone)

Completed
  • Multiple Myeloma
  • MOR03087 phase 1 dose escalation
  • +4 more
  • Vienna, Austria
  • +9 more
Nov 12, 2021

Membranous Nephropathy Trial in Bergamo, Ranica (MOR202)

Recruiting
  • Membranous Nephropathy
  • Bergamo, BG, Italy
  • +1 more
Mar 4, 2022

Glomerulonephritis, Membranous Nephropathy, antiPLA2R Positive Trial in Worldwide (MOR202)

Active, not recruiting
  • Glomerulonephritis
  • +2 more
  • Tbilisi, Georgia
  • +24 more
Aug 23, 2022

Glomerulonephritis, Membranous, antiPLA2R Positive Trial in Worldwide (MOR202)

Completed
  • Glomerulonephritis, Membranous
  • antiPLA2R Positive
  • Azusa, California
  • +44 more
Dec 12, 2022

Antibody-mediated Rejection Trial in Vienna, Berlin (Felzartamab, Placebo)

Recruiting
  • Antibody-mediated Rejection
  • Vienna, Austria
  • +1 more
Aug 23, 2022

Immunoglobulin A (IgA) Nephropathy Trial in Worldwide (Felzartamab, Placebo)

Recruiting
  • Immunoglobulin A (IgA) Nephropathy
  • Oxnard, California
  • +59 more
Dec 12, 2022

Coronary Artery Disease Trial in Worldwide (Percutaneous coronary intervention)

Active, not recruiting
  • Coronary Artery Disease
  • Percutaneous coronary intervention
  • Epping, Australia
  • +51 more
Dec 8, 2021

NASH - Nonalcoholic Steatohepatitis Trial in Worldwide (VK2809, Placebos)

Recruiting
  • NASH - Nonalcoholic Steatohepatitis
  • Birmingham, Alabama
  • +107 more
Mar 1, 2022

NSCLC Trial in Worldwide (Pembrolizumab, Lenvatinib, Placebo for lenvatinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Pembrolizumab
  • +2 more
  • Anchorage, Alaska
  • +161 more
Oct 26, 2022

Pilot Study of Cardiac MR in Patients With Muscular Dystrophy

Recruiting
  • Muscular Dystrophies
  • +3 more
    • Washington, District of Columbia
      Children's National Health System
    Mar 1, 2022

    Acute Myeloid Leukemia Trial in Worldwide (guadecitabine, Treatment Choice (TC))

    Completed
    • Acute Myeloid Leukemia
    • Los Angeles, California
    • +94 more
    Sep 5, 2021

    Urinary Bladder Tumors Trial in Worldwide (Pembrolizumab, Conventional Radiotherapy (Bladder only), Conventional Radiotherapy

    Recruiting
    • Urinary Bladder Neoplasms
    • Washington, District of Columbia
    • +120 more
    Jan 19, 2023

    Pulmonary Disease, Chronic Obstructive Trial in Worldwide (BEA 2180 BR, Tiotropium Bromide, Placebo)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • BEA 2180 BR
    • +2 more
    • Jasper, Alabama
    • +177 more
    Jul 30, 2021

    Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)

    Active, not recruiting
    • Endometrial Cancer
    • Uterine Carcinosarcoma
    • New York, New York
    • +2 more
    Apr 4, 2022

    Clear Cell Renal Cell Carcinoma Trial in Worldwide (Belzutifan, Pembrolizumab, Placebo)

    Recruiting
    • Clear Cell Renal Cell Carcinoma
    • Duarte, California
    • +250 more
    Jan 27, 2023

    Nonalcoholic Steatohepatitis Trial in Worldwide (Placebo, Cenicriviroc)

    Terminated
    • Nonalcoholic Steatohepatitis
    • Birmingham, Alabama
    • +345 more
    Feb 11, 2022

    Myocardial Infarction Trial in Worldwide (Empagliflozin, Placebo)

    Recruiting
    • Myocardial Infarction
    • Alexander City, Alabama
    • +464 more
    Aug 22, 2022

    Metastatic Colorectal Cancer Trial in Worldwide (Xilonix, Placebo)

    Terminated
    • Metastatic Colorectal Cancer
    • Birmingham, Alabama
    • +112 more
    Jun 28, 2021

    Acute Coronary Syndrome Trial in Worldwide (Milvexian, Placebo)

    Not yet recruiting
    • Acute Coronary Syndrome
    • Alexander City, Alabama
    • +862 more
    Feb 23, 2023

    cuTe Heart failUre:pRospective Echocardiographic and Clinical

    Recruiting
    • Heart Failure
    • +3 more
    • Transthoracic Echocardiography
    • Sydney, Australia
    • +30 more
    Jan 10, 2022

    Solid Tumors Trial in Worldwide (Pembrolizumab, Standard of Care (SOC))

    Recruiting
    • Solid Tumors
    • Tucson, Arizona
    • +374 more
    Aug 22, 2022

    Ulcerative Colitis Trial in Worldwide (RPC1063, Placebo)

    Completed
    • Ulcerative Colitis
    • Sun City, Arizona
    • +371 more
    Aug 6, 2021

    Acute Coronary Syndrome Trial in Worldwide (Apolipoprotein A-I [human] (apoA-I), Placebo)

    Recruiting
    • Acute Coronary Syndrome
    • Apolipoprotein A-I [human] (apoA-I)
    • Placebo
    • Alexander City, Alabama
    • +930 more
    Aug 8, 2022

    Effective Management of Calcific Aortic Stenosis in the Elderly

    Completed
    • Calcific Aortic Stenosis
      • (no location specified)
      Aug 6, 2019

      Pancreatic Ductal Carcinoma Trial in Worldwide (Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20), Placebo,

      Terminated
      • Pancreatic Ductal Carcinoma
      • Biological: PEGylated Recombinant Human Hyaluronidase (PEGPH20)
      • +3 more
      • Mobile, Alabama
      • +216 more
      Jun 30, 2020